Growth Metrics

Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)

Pharma-Bio Serv posted quarterly Operating Leases of $28834.0 for Q4 2024, down 85.14% year-on-year from $194035.0 in Q4 2023, and down 59.59% on a QoQ basis from $71362.0 in Q3 2024.

Pharma-Bio Serv (PBSV) has 5 years of Operating Leases data on file, last reported at $28834.0 in Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases fell 85.14% year-over-year to $28834.0; the trailing twelve-month figure through Oct 2024 stood at $28834.0 (down 85.14% YoY), and the FY2024 full-year result was $28834.0, down 85.14% from the prior year.
  • Operating Leases for Q4 2024 stood at $28834.0, down from $71362.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $729389.0 in Q1 2020 and bottomed at $28834.0 in Q4 2024.
  • The 5-year median for Operating Leases is $400460.0 (2022), against an average of $393144.6.
  • The widest annual swing landed in 2021, when Operating Leases slipped 18.42%; it then plunged 85.14% in 2024.
  • A 5-year view of Operating Leases shows it stood at $629979.0 in 2020, then decreased by 22.64% to $487364.0 in 2021, then dropped by 28.9% to $346509.0 in 2022, then sank by 44.0% to $194035.0 in 2023, then slumped by 85.14% to $28834.0 in 2024.
  • The last three Operating Leases figures came in at $28834.0 (Q4 2024), $71362.0 (Q3 2024), and $113044.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Pharma-Bio Serv - - 722,374.00

Historic Data

Download Data 🔒
DateValue
Oct 31, 2024 28,834.00
Jul 31, 2024 71,362.00
Apr 30, 2024 113,044.00
Jan 31, 2024 153,993.00
Oct 31, 2023 194,035.00
Jul 31, 2023 233,276.00
Apr 30, 2023 271,737.00
Jan 31, 2023 309,564.00
Oct 31, 2022 346,509.00
Jul 31, 2022 382,716.00
Apr 30, 2022 418,204.00
Jan 31, 2022 453,278.00
Oct 31, 2021 487,364.00
Jul 31, 2021 523,960.00
Apr 30, 2021 559,873.00
Jan 31, 2021 595,072.00
Oct 31, 2020 629,979.00
Jul 31, 2020 663,786.00
Apr 30, 2020 696,916.00
Jan 31, 2020 729,389.00